7 research outputs found

    Π Π°Π·Π²ΠΈΡ‚ΠΈΠ΅ государствСнно-частного партнСрства ΠΊΠ°ΠΊ стратСгия ΠΌΠΎΠ΄Π΅Ρ€Π½ΠΈΠ·Π°Ρ†ΠΈΠΈ соврСмСнной России

    Get PDF
    The article analyses legal approaches to the public private partnership as the form of interaction between public institutions and business, there are outspoken concrete proposals and recommendations related with the perspectives of its development in Russia.Π’ ΡΡ‚Π°Ρ‚ΡŒΠ΅ Π°Π½Π°Π»ΠΈΠ·ΠΈΡ€ΡƒΡŽΡ‚ΡΡ ΠΏΡ€Π°Π²ΠΎΠ²Ρ‹Π΅ ΠΏΠΎΠ΄Ρ…ΠΎΠ΄Ρ‹ ΠΊ государствСнно-частному партнСрству ΠΊΠ°ΠΊ Ρ„ΠΎΡ€ΠΌΠ΅ взаимодСйствия ΠΏΡƒΠ±Π»ΠΈΡ‡Π½Ρ‹Ρ… институтов ΠΈ бизнСса, Π²Ρ‹ΡΠΊΠ°Π·Ρ‹Π²Π°ΡŽΡ‚ΡΡ ΠΊΠΎΠ½ΠΊΡ€Π΅Ρ‚Π½Ρ‹Π΅ прСдлоТСния ΠΈ Ρ€Π΅ΠΊΠΎΠΌΠ΅Π½Π΄Π°Ρ†ΠΈΠΈ ΠΎΡ‚Π½ΠΎΡΠΈΡ‚Π΅Π»ΡŒΠ½ΠΎ пСрспСктив Π΅Π³ΠΎ развития Π² России

    Π—Π°Ρ€ΡƒΠ±Π΅ΠΆΠ½Ρ‹ΠΉ ΠΎΠΏΡ‹Ρ‚ ΠΈ ΠΌΠΎΠ΄Π΅Π»ΠΈ ΠΏΡ€Π°Π²ΠΎΠ²ΠΎΠ³ΠΎ рСгулирования ΠΏΡƒΠ±Π»ΠΈΡ‡Π½ΠΎ-частного партнСрства

    Get PDF
    The author analyses foreign experience of public-private partnership, models of legal regulation of public-private partnership in foreign countries, principles of interaction between public institutions and business in realization of joint projects, there are outspoken concrete recommendations related with the perspectives of development of public-private partnership.Π’ ΡΡ‚Π°Ρ‚ΡŒΠ΅ Π°Π½Π°Π»ΠΈΠ·ΠΈΡ€ΡƒΡŽΡ‚ΡΡ Π·Π°Ρ€ΡƒΠ±Π΅ΠΆΠ½Ρ‹ΠΉ ΠΎΠΏΡ‹Ρ‚ ΠΏΡƒΠ±Π»ΠΈΡ‡Π½ΠΎ-частного партнСрства, ΠΌΠΎΠ΄Π΅Π»ΠΈ ΠΏΡ€Π°Π²ΠΎΠ²ΠΎΠ³ΠΎ рСгулирования ΠΏΡƒΠ±Π»ΠΈΡ‡Π½ΠΎ-частного партнСрства Π² Π·Π°Ρ€ΡƒΠ±Π΅ΠΆΠ½Ρ‹Ρ… странах, ΠΏΡ€ΠΈΠ½Ρ†ΠΈΠΏΡ‹ взаимодСйствия ΠΏΡƒΠ±Π»ΠΈΡ‡Π½Ρ‹Ρ… институтов ΠΈ бизнСса ΠΏΠΎ Ρ€Π΅Π°Π»ΠΈΠ·Π°Ρ†ΠΈΠΈ совмСстных ΠΏΡ€ΠΎΠ΅ΠΊΡ‚ΠΎΠ², Π²Ρ‹ΡΠΊΠ°Π·Ρ‹Π²Π°ΡŽΡ‚ΡΡ ΠΊΠΎΠ½ΠΊΡ€Π΅Ρ‚Π½Ρ‹Π΅ прСдлоТСния ΠΎΡ‚Π½ΠΎΡΠΈΡ‚Π΅Π»ΡŒΠ½ΠΎ пСрспСктив развития ΠΏΡƒΠ±Π»ΠΈΡ‡Π½ΠΎ-частного партнСрства

    Π₯арактСристика эпидСмиологичСской ситуации ΠΏΠΎ COVID-19 Π² Российской Π€Π΅Π΄Π΅Ρ€Π°Ρ†ΠΈΠΈ Π² 2020 Π³.

    No full text
    Background.The COVID-19 epidemic in the Russian Federation, which began in March 2020, caused serious damage to health of the population and led to severe economic losses. By December 28, 2020, 3 078 035 cases of COVID-19 and 55 265 lethal outcomes were registered in the country. The population of all territorial subjects of the country is involved in the epidemic process of COVID-19. The severe epidemiological situation made it necessary to conduct an analysis to identify the factors that determine the high intensity of the epidemic process, as well as the population groups with the highest risk of SARS-CoV-2 infection. Aims to study the patterns of SARS-CoV-2 spread and the epidemiological features of the initial stage of the COVID-19 pandemic in the Russian Federation in 2020. Methods.An epidemiological analysis of the COVID-19 situation in the Russian Federation was carried out to determine the dynamics of morbidity, the gender proportion and age structure of patients, the proportion of hospitalized patients, the ratio of various forms of infection, the social and professional status of patients. Standard methods of descriptive statistics Microsoft Excel and STATISTICA 12.0 (StatSoft, USA) were used for statistical processing. The mean values were estimated with a 95% confidence interval [95% CI] (the exact Klopper Pearson method). Results.During the observation time (2020), several periods were identified in the dynamics of the new COVID-19 cases detection: the period of importation of SARS-CoV-2 and the increase in morbidity, the period of epidemic decline, the period of autumn growth, the period of sustained high incidence of COVID-19. It was found that people over 70 years of age are the group with the highest risk of infection and a more severe course of COVID-19. The presence of target contingents among social and professional groups of the population, which should include medical workers, retired person, employees of educational institutions, law enforcement agencies, transport, who require special attention and medical and social support, was shown. Conclusions.The analysis showed that the large-scale spread of COVID-19 requires in-depth epidemiological studies and the development of additional disease control measures, taking into account the dynamics of the incidence of this socially significant infection.ОбоснованиС.ЭпидСмияCOVID-19вРоссийской Π€Π΅Π΄Π΅Ρ€Π°Ρ†ΠΈΠΈ, Π½Π°Ρ‡Π°Π²ΡˆΠΈΡΡŒΠ²ΠΌΠ°Ρ€Ρ‚Π΅ 2020 Π³., нанСсла ΡΠ΅Ρ€ΡŒΠ΅Π·Π½Π΅ΠΉΡˆΠΈΠΉ ΡƒΡ‰Π΅Ρ€Π± Π·Π΄ΠΎΡ€ΠΎΠ²ΡŒΡŽ насСлСнияипривСлактяТСлым экономичСским потСрям.К28 дСкабря 2020 Π³.встранС зарСгистрировано 3 078 035 случаяCOVID-19ΠΈ55 265 Π»Π΅Ρ‚Π°Π»ΡŒΠ½Ρ‹Ρ… исходов.ВэпидСмичСский процСссCOVID-19 Π²ΠΎΠ²Π»Π΅Ρ‡Π΅Π½ΠΎ насСлСниС всСх ΡΡƒΠ±ΡŠΠ΅ΠΊΡ‚ΠΎΠ² Российской Π€Π΅Π΄Π΅Ρ€Π°Ρ†ΠΈΠΈ. ВяТСлая эпидСмиологичСская ситуациявстранС обусловила Π½Π΅ΠΎΠ±Ρ…ΠΎΠ΄ΠΈΠΌΠΎΡΡ‚ΡŒ провСдСния анализасвыявлСниСм Ρ„Π°ΠΊΡ‚ΠΎΡ€ΠΎΠ², ΠΎΠΏΡ€Π΅Π΄Π΅Π»ΡΡŽΡ‰ΠΈΡ… Π²Ρ‹ΡΠΎΠΊΡƒΡŽ ΠΈΠ½Ρ‚Π΅Π½ΡΠΈΠ²Π½ΠΎΡΡ‚ΡŒ эпидСмичСского процСсса,Π°Ρ‚Π°ΠΊΠΆΠ΅ Π³Ρ€ΡƒΠΏΠΏ насСлСнияснаиболСС высоким риском инфицированияSARS-CoV-2. ЦСль исслСдования ΠΈΠ·ΡƒΡ‡ΠΈΡ‚ΡŒ закономСрности распространСнияSARS-CoV-2иэпидСмиологичСскиС особСнности Π½Π°Ρ‡Π°Π»ΡŒΠ½ΠΎΠ³ΠΎ этапа ΠΏΠ°Π½Π΄Π΅ΠΌΠΈΠΈCOVID-19вРоссийской Π€Π΅Π΄Π΅Ρ€Π°Ρ†ΠΈΠΈΠ²2020 Π³. ΠœΠ΅Ρ‚ΠΎΠ΄Ρ‹.ΠŸΡ€ΠΎΠ²Π΅Π΄Π΅Π½ эпидСмиологичСский Π°Π½Π°Π»ΠΈΠ· ситуациипоCOVID-19вРоссийской ЀСдСрациисопрСдСлСниСм Π΄ΠΈΠ½Π°ΠΌΠΈΠΊΠΈ заболСваСмости, Π³Π΅Π½Π΄Π΅Ρ€Π½ΠΎΠΉ пропорцииивозрастной структуры Π·Π°Π±ΠΎΠ»Π΅Π²ΡˆΠΈΡ…, ΡƒΠ΄Π΅Π»ΡŒΠ½ΠΎΠ³ΠΎ вСса госпитализированных ΠΏΠ°Ρ†ΠΈΠ΅Π½Ρ‚ΠΎΠ², ΡΠΎΠΎΡ‚Π½ΠΎΡˆΠ΅Π½ΠΈΡ Ρ€Π°Π·Π»ΠΈΡ‡Π½Ρ‹Ρ… Ρ„ΠΎΡ€ΠΌ ΠΈΠ½Ρ„Π΅ΠΊΡ†ΠΈΠΈ, ΡΠΎΡ†ΠΈΠ°Π»ΡŒΠ½ΠΎΠ³ΠΎΠΈΠΏΡ€ΠΎΡ„Π΅ΡΡΠΈΠΎΠ½Π°Π»ΡŒΠ½ΠΎΠ³ΠΎ статуса Π·Π°Π±ΠΎΠ»Π΅Π²ΡˆΠΈΡ….ДлястатистичСской ΠΎΠ±Ρ€Π°Π±ΠΎΡ‚ΠΊΠΈ ΠΈΡΠΏΠΎΠ»ΡŒΠ·ΠΎΠ²Π°Π½Ρ‹ стандартныС ΠΌΠ΅Ρ‚ΠΎΠ΄Ρ‹ ΠΎΠΏΠΈΡΠ°Ρ‚Π΅Π»ΡŒΠ½ΠΎΠΉ статистики Microsoft ExcelΠΈSTATISTICA 12.0 (StatSoft, БША). Π‘Ρ€Π΅Π΄Π½ΠΈΠ΅ значСния оцСнивалисучСтом 95% Π΄ΠΎΠ²Π΅Ρ€ΠΈΡ‚Π΅Π»ΡŒΠ½ΠΎΠ³ΠΎ ΠΈΠ½Ρ‚Π΅Ρ€Π²Π°Π»Π° [95% Π”Π˜] (ΠΏΠΎ Ρ‚ΠΎΡ‡Π½ΠΎΠΌΡƒ ΠΌΠ΅Ρ‚ΠΎΠ΄Ρƒ ΠšΠ»ΠΎΠΏΠΏΠ΅Ρ€Π°ΠŸΠΈΡ€ΡΠΎΠ½Π°). Π Π΅Π·ΡƒΠ»ΡŒΡ‚Π°Ρ‚Ρ‹.ЗаврСмя наблюдСния (2020 Π³.) Π²Ρ‹Π΄Π΅Π»Π΅Π½ΠΎ нСсколько ΠΏΠ΅Ρ€ΠΈΠΎΠ΄ΠΎΠ²Π²Π΄ΠΈΠ½Π°ΠΌΠΈΠΊΠ΅ выявлСния Π½ΠΎΠ²Ρ‹Ρ… случаСвCOVID-19: ΠΏΠ΅Ρ€ΠΈΠΎΠ΄ Π·Π°Π²ΠΎΠ·Π°SARS-CoV-2ироста заболСваСмости, ΠΏΠ΅Ρ€ΠΈΠΎΠ΄ эпидСмичСского Π·Π°Ρ‚ΠΈΡˆΡŒΡ, ΠΏΠ΅Ρ€ΠΈΠΎΠ΄ осСннСго подъСма, ΠΏΠ΅Ρ€ΠΈΠΎΠ΄ устойчиво высокого уровня заболСваСмостиCOVID-19. УстановлСно,Ρ‡Ρ‚ΠΎΠ»ΠΈΡ†Π° ΡΡ‚Π°Ρ€ΡˆΠ΅ 70 Π»Π΅Ρ‚ ΡΠ²Π»ΡΡŽΡ‚ΡΡ группойснаиболСС высоким риском зараТСнияиболСС тяТСлым Ρ‚Π΅Ρ‡Π΅Π½ΠΈΠ΅ΠΌCOVID-19. Показано Π½Π°Π»ΠΈΡ‡ΠΈΠ΅ Ρ†Π΅Π»Π΅Π²Ρ‹Ρ… ΠΊΠΎΠ½Ρ‚ΠΈΠ½Π³Π΅Π½Ρ‚ΠΎΠ² срСди ΡΠΎΡ†ΠΈΠ°Π»ΡŒΠ½Ρ‹Ρ…ΠΈΠΏΡ€ΠΎΡ„Π΅ΡΡΠΈΠΎΠ½Π°Π»ΡŒΠ½Ρ‹Ρ… Π³Ρ€ΡƒΠΏΠΏ насСлСния,кчислу ΠΊΠΎΡ‚ΠΎΡ€Ρ‹Ρ… слСдуСт отнСсти мСдицинских Ρ€Π°Π±ΠΎΡ‚Π½ΠΈΠΊΠΎΠ², пСнсионСров, Ρ€Π°Π±ΠΎΡ‚Π½ΠΈΠΊΠΎΠ² ΠΎΠ±Ρ€Π°Π·ΠΎΠ²Π°Ρ‚Π΅Π»ΡŒΠ½Ρ‹Ρ… ΡƒΡ‡Ρ€Π΅ΠΆΠ΄Π΅Π½ΠΈΠΉ, ΠΏΡ€Π°Π²ΠΎΠΎΡ…Ρ€Π°Π½ΠΈΡ‚Π΅Π»ΡŒΠ½Ρ‹Ρ… ΠΎΡ€Π³Π°Π½ΠΎΠ², транспорта, ΠΊΠΎΡ‚ΠΎΡ€Ρ‹Π΅ Ρ‚Ρ€Π΅Π±ΡƒΡŽΡ‚ особого вниманияимСдико-ΡΠΎΡ†ΠΈΠ°Π»ΡŒΠ½ΠΎΠΉ ΠΏΠΎΠ΄Π΄Π΅Ρ€ΠΆΠΊΠΈ. Π—Π°ΠΊΠ»ΡŽΡ‡Π΅Π½ΠΈΠ΅.ΠŸΡ€ΠΎΠ²Π΅Π΄Π΅Π½Π½Ρ‹ΠΉ Π°Π½Π°Π»ΠΈΠ· ΠΏΠΎΠΊΠ°Π·Π°Π»,Ρ‡Ρ‚ΠΎΠΌΠ°ΡΡˆΡ‚Π°Π±Π½ΠΎΠ΅ распространСниС COVID-19 Ρ‚Ρ€Π΅Π±ΡƒΠ΅Ρ‚ провСдСния ΡƒΠ³Π»ΡƒΠ±Π»Π΅Π½Π½Ρ‹Ρ… эпидСмиологичСских исслСдованийиразработки Π΄ΠΎΠΏΠΎΠ»Π½ΠΈΡ‚Π΅Π»ΡŒΠ½Ρ‹Ρ… противоэпидСмичСских мСроприятийсучСтом Π΄ΠΈΠ½Π°ΠΌΠΈΠΊΠΈ заболСваСмости этой ΡΠΎΡ†ΠΈΠ°Π»ΡŒΠ½ΠΎ Π·Π½Π°Ρ‡ΠΈΠΌΠΎΠΉ ΠΈΠ½Ρ„Π΅ΠΊΡ†ΠΈΠ΅ΠΉ

    Identifying counterfeit medicines using near infrared spectroscopy

    No full text
    Counterfeit medicines are a growing threat to public health across the world and screening methods are needed to allow their rapid identification. A counterfeiter must duplicate both the physical characteristics and the chemical content of a proprietary product to avoid it being detected as a counterfeit product and this is almost impossible to get right. Counterfeit proprietary medicines are, therefore, relatively easy to identify by near infrared (NIR) spectroscopy which can detect physical as well as chemical differences between products by simple spectral comparison. Identifying generic products is more difficult as they use different excipients in the tablet or capsule matrix. Nevertheless, using appropriate models and a large library, NIR spectroscopy can detect counterfeit generic versions. Detecting sub-standard proprietary medicines can be carried out with NIR spectroscopy models and the most widely used is partial least squares regression (PLSR). General rules for generating accurate quantitative models are easy to describe. Quantifying the active pharmaceutical ingredient (API) in generic products can also be carried out using PLSR models with calibration samples generated by manufacturing laboratory samples or by collecting many generic versions of a medicine so as to obtain a good range of the API content in tablets and capsules. Using hand-held instruments or mobile laboratories allows NIR spectrometers to be taken to places where analyses may be made quickly, rather than taking the samples to a laboratory. This has the enormous advantage that the screening of large numbers of samples may be made in pharmacies and wholesalers. Imaging can bring a whole new dimension to NIR spectroscopy to allow the identification of the API and individual excipients as well as measuring the particle sizes of components and giving a measure of the homogeneity of the matrix. The effect of water on potential misidentifications may be obviated by only using blister-packed samples, having large spectral libraries subjected to different humidities or omitting the spectral region where water absorbs.Peer reviewe
    corecore